Although significant progress has been made in elucidating the molecular and cellular mechanisms underlying drug-induced neurotoxicity, key questions remain
At week 36, 27.1% of participants receiving combination therapy simultaneously achieved complete skin clearance, defined as a Psoriasis Area and Severity Index (PASI) 100 response, and at least 10% weight reduction, compared with 5.8% of those receiving ixekizumab alone (risk difference [RD], 21.2%
Having the weight conversation with your provider Being overweightand talking about itcan sometimes be difficult
No effects of sex, age, race, ethnicity, renal function or injection site used on semaglutide exposure were observed [6]
Patients should always inform their GP or prescribing clinician about all medications they are taking, including over-the-counter preparations